NPPA notified regarding the computation of the retail price of myo-Inositol IP 600 mg + Metformin Hydrochloride IP 500 mg (As sustained release) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer)

Dec 11, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Complianceclass="MsoNormal">The National Pharmaceutical Pricing Authority (NPPA) on December 08, 2025, notified regarding the computation of the retail price of myo-Inositol IP 600 mg + Metformin Hydrochloride IP 500 mg (As sustained release) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer).

It states that the price of each uncoated bilayered tablet containing:- myo-Inositol IP 600 mg + Metformin Hydrochloride IP 500 mg (As sustained release) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer) has been revised to Rs. 23.59/-.

 

[Notification no: 19(4891)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT